Prime Capital Investment Advisors LLC Buys Shares of 2,786 Centene Co. (NYSE:CNC)

Prime Capital Investment Advisors LLC bought a new stake in shares of Centene Co. (NYSE:CNC) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,786 shares of the company’s stock, valued at approximately $210,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. EP Wealth Advisors LLC lifted its holdings in shares of Centene by 1.0% during the 1st quarter. EP Wealth Advisors LLC now owns 13,604 shares of the company’s stock valued at $1,068,000 after purchasing an additional 133 shares during the last quarter. WR Wealth Planners LLC lifted its holdings in shares of Centene by 41.4% during the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after purchasing an additional 137 shares during the last quarter. Whittier Trust Co. lifted its holdings in shares of Centene by 10.0% during the 2nd quarter. Whittier Trust Co. now owns 1,562 shares of the company’s stock valued at $104,000 after purchasing an additional 142 shares during the last quarter. Mount Yale Investment Advisors LLC lifted its holdings in shares of Centene by 2.1% during the 3rd quarter. Mount Yale Investment Advisors LLC now owns 8,082 shares of the company’s stock valued at $608,000 after purchasing an additional 167 shares during the last quarter. Finally, Meridian Management Co. lifted its holdings in shares of Centene by 0.3% during the 2nd quarter. Meridian Management Co. now owns 64,721 shares of the company’s stock valued at $4,291,000 after purchasing an additional 189 shares during the last quarter. Institutional investors own 93.63% of the company’s stock.

Centene Trading Down 2.1 %

CNC opened at $57.46 on Monday. Centene Co. has a one year low of $57.25 and a one year high of $81.42. The stock has a market capitalization of $29.01 billion, a PE ratio of 9.98, a P/E/G ratio of 0.79 and a beta of 0.49. The business’s 50 day moving average price is $68.06 and its 200 day moving average price is $70.99. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10.

Insider Activity at Centene

In other news, CEO Sarah London purchased 4,117 shares of the firm’s stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the purchase, the chief executive officer now directly owns 667,229 shares of the company’s stock, valued at approximately $40,567,523.20. This trade represents a 0.62 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Andrew Lynn Asher purchased 17,200 shares of the firm’s stock in a transaction on Wednesday, November 13th. The shares were purchased at an average price of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the purchase, the chief financial officer now directly owns 486,847 shares of the company’s stock, valued at $28,305,284.58. This represents a 3.66 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.33% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Oppenheimer reduced their target price on Centene from $110.00 to $95.00 and set an “outperform” rating for the company in a research note on Monday, July 29th. Robert W. Baird reduced their target price on Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a research note on Friday, October 25th. Wells Fargo & Company reduced their target price on Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. Stephens restated an “equal weight” rating and issued a $78.00 target price on shares of Centene in a research note on Monday, August 5th. Finally, Sanford C. Bernstein cut their price target on Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 30th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $83.92.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.